Citadel Advisors
IMGN

Citadel Advisors’s Immunogen Inc IMGN Stock Holding History

Citadel Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-795,458
Closed -$23.6M – 15809
2023
Q4 		$23.6M Sell
795,458
-492,084
-38% -$9.8M ﹤0.01% 1855
2023
Q3 		$20.4M Buy
1,287,542
+359,302
+39% +$5.98M ﹤0.01% 1830
2023
Q2 		$17.5M Sell
928,240
-46,818
-5% -$553K ﹤0.01% 2022
2023
Q1 		$3.74M Buy
975,058
+948,435
+3,562% +$4.04M ﹤0.01% 4291
2022
Q4 		$132K Sell
26,623
-1,413,786
-98% -$7.67M ﹤0.01% 10807
2022
Q3 		$6.88M Sell
1,440,409
-409,632
-22% -$2.16M ﹤0.01% 3347
2022
Q2 		$8.32M Buy
1,850,041
+1,112,373
+151% +$4.83M ﹤0.01% 2928
2022
Q1 		$3.51M Sell
737,668
-397,483
-35% -$2.2M ﹤0.01% 4863
2021
Q4 		$8.42M Buy
+1,135,151
New +$7.05M ﹤0.01% 3354
2021
Q3 		– Sell
-623,564
Closed -$3.6M – 14913
2021
Q2 		$4.11M Buy
623,564
+407,084
+188% +$2.84M ﹤0.01% 4872
2021
Q1 		$1.75M Sell
216,480
-1,518,367
-88% -$12.4M ﹤0.01% 6721
2020
Q4 		$11.2M Buy
1,734,847
+1,097,928
+172% +$6.4M ﹤0.01% 2497
2020
Q3 		$2.29M Buy
636,919
+470,663
+283% +$1.9M ﹤0.01% 4474
2020
Q2 		$765K Sell
166,256
-492,808
-75% -$2.1M ﹤0.01% 6326
2020
Q1 		$2.25M Sell
659,064
-622,227
-49% -$2.72M ﹤0.01% 3944
2019
Q4 		$6.54M Buy
1,281,291
+781,347
+156% +$2.65M ﹤0.01% 2740
2019
Q3 		$1.21M Sell
499,944
-513,376
-51% -$1.36M ﹤0.01% 5259
2019
Q2 		$2.2M Buy
1,013,320
+698,528
+222% +$1.65M ﹤0.01% 4356
2019
Q1 		$853K Sell
314,792
-2,305,912
-88% -$9.99M ﹤0.01% 5880
2018
Q4 		$12.6M Buy
2,620,704
+315,028
+14% +$1.91M 0.01% 1654
2018
Q3 		$21.8M Buy
2,305,676
+437,848
+23% +$4.21M 0.01% 1326
2018
Q2 		$18.2M Buy
1,867,828
+1,415,096
+313% +$14.9M 0.01% 1385
2018
Q1 		$4.76M Buy
452,732
+289,783
+178% +$2.86M ﹤0.01% 2517
2017
Q4 		$1.04M Sell
162,949
-36,890
-18% -$228K ﹤0.01% 4594
2017
Q3 		$1.53M Buy
+199,839
New +$1.33M ﹤0.01% 3739
2017
Q1 		– Sell
-185,518
Closed -$541K – 8186
2016
Q4 		$379K Buy
185,518
+22,933
+14% +$46K ﹤0.01% 5332
2016
Q3 		$436K Sell
162,585
-4,517
-3% -$13.1K ﹤0.01% 5063
2016
Q2 		$515K Buy
+167,102
New +$1.05M ﹤0.01% 4440
2015
Q4 		– Sell
-40,502
Closed -$499K – 9328
2015
Q3 		$389K Sell
40,502
-91,933
-69% -$1.34M ﹤0.01% 5164
2015
Q2 		$1.9M Buy
132,435
+41,255
+45% +$453K ﹤0.01% 3115
2015
Q1 		$816K Sell
91,180
-95,972
-51% -$695K ﹤0.01% 4212
2014
Q4 		$1.14M Buy
187,152
+58,148
+45% +$532K ﹤0.01% 3603
2014
Q3 		$1.37M Sell
129,004
-23,044
-15% -$261K ﹤0.01% 3310
2014
Q2 		$1.8M Buy
152,048
+54,105
+55% +$679K ﹤0.01% 2830
2014
Q1 		$1.46M Buy
97,943
+3,868
+4% +$61K ﹤0.01% 2956
2013
Q4 		$1.38M Buy
94,075
+47,274
+101% +$727K ﹤0.01% 2905
2013
Q3 		$797K Buy
46,801
+33,213
+244% +$584K ﹤0.01% 3328
2013
Q2 		$225K Buy
+13,588
New +$220K ﹤0.01% 4564

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's IMGN Position: Q1 2024 in Review

Citadel Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 795,458 shares — an estimated $23.6M sold.

Citadel Advisors first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $23.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Citadel Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 795,458 Immunogen Inc shares in Q1 2024, an estimated $23.6M.
  • Citadel Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
  • Citadel Advisors's Immunogen Inc position peaked at $23.6M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.